Status: Recruiting
Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: NeoChordUpdated: Jul 10, 2020Locations: 5Duration: 5 Years
Eligibility criteria
Has Grade III Moderate or Grade IV Severe degenerative or mixed disease mitral v... [+1]
Heavily calcified valves [+5]